Monday, November 16, 2026Every story links to its original source.

Genome News

Genomics news, traced to the source.

Reading

studyarchive2 min read

SensiTyper predicted gonorrhoea antibiotic susceptibility in 13,701 genomes

Illustrative photo by Czapp Árpád, Pexels LicenseImage licenceFull-size image

SensiTyper predicted whether gonorrhoea bacteria were susceptible to four antibiotics with 98.9-100% sensitivity and specificity in an analytical validation using 13,701 genomes. Golparian, Sánchez-Busó and Unemo reported the findings in 2026. The genomes came from 68 countries and samples collected in 1928-2024. Predictions reached that range for ceftriaxone, ciprofloxacin, spectinomycin and zoliflodacin. Results differed for two other antibiotics, with a limitation in identifying gepotidacin resistance. The framework also generated individualized treatment recommendations from its predictions.

SensiTyper applies rules to whole-genome sequencing data, which records a bacterium's genetic information, to predict which antibiotics it is susceptible to. The validation included bacteria grown in culture and clinical molecular samples. The authors checked the predictions against previous genetic data and phenotypic data, meaning observations of how the bacteria responded to antibiotics.

For azithromycin, sensitivity was 92.5% and specificity was 97.1%. Sensitivity measures how well the framework identifies susceptible bacteria; specificity measures how well it identifies those that are not susceptible. Gepotidacin predictions had 100% sensitivity but 0% specificity, so they failed to distinguish bacteria that were not susceptible to the drug.

The authors reported that low-level gepotidacin resistance observed in antibiotic testing was not caused by the only known genetic resistance determinants, GyrA A92T plus ParC D86N. That finding limits the use of those genetic markers to predict susceptibility to gepotidacin.

The SensiTreat module turns the predicted susceptibility profiles into a sequence of individualized treatment recommendations. It also allows alternative approaches to managing antibiotic use, such as giving priority to ciprofloxacin. The aim is to guide antibiotic choice using information about the bacteria causing a person's infection.

Extensively drug-resistant (XDR) Neisseria gonorrhoeae strains threaten current empirical treatment, the authors said. Empirical treatment means choosing an antibiotic without susceptibility information for the infection being treated. SensiTyper flags XDR isolates for expert follow-up, testing to confirm that the infection has cleared, and comprehensive tracing of contacts.

The framework links bacterial genetic data to antibiotic treatment recommendations for gonorrhoea. Its performance varied by drug: predictions for four antibiotics had 98.9-100% sensitivity and specificity, while gepotidacin predictions failed to identify bacteria that were not susceptible.

Written by the Genomes desk from the primary source cited and linked above and checked against it. Research use only; not medical advice. Corrections: [email protected].

More from the archive

Back to the latest · Archive